Table 3 Predictors of HCC recurrence

Gender

Female

3 (50%)

20 (30.3%)

0.376

Male

3 (50%)

46 (69.7%)

Smoking

Yes

0 (0%)

19 (28.8%)

0.331

No

6 (100%)

47 (71.2%)

Diabetes mellitus

Yes

2 (33.3%)

21 (31.8%)

1

No

4 (66.7%)

45 (68.2%)

Child score (mean/SD)

5.67 (0.82)

5.53 (0.64)

0.743

Hemoglobin (mean/SD)

12.27 (1.51)

13.02 (1.76)

0.232

Platelets (mean/SD)

146.67 (63.89)

165.45 (44.29)

0.684

AFP (baseline) (median/IQR)

59.75 (41–132)

43 (12–124)

0.293

AFP (post-ttt) (median/IQR)

100.8 (76.4–213)

12.75 (6.8–24.8)

0.011

Number of HFLs (mean/SD)

1.00 (0.0)

1.18 (0.46)

0.557

Size of HFLs (mean/SD)

3.15 cm (0.74)

3.48 cm (1.5)

0.570

Treatment modality

Hepatectomy

3 (50%)

28 (42.4%)

1

Percutaneous microwave ablation

3 (50%)

34 (51.5%)

Intraoperative microwave ablation

0 (0%)

4 (6.1%)

Post-treatment portal vein thrombosis

Yes

0 (0%)

1 (1.5%)

1

No

6 (100%)

65 (98.5%)

Post-treatment clinical decompensation

Yes

1 (16.7%)

10 (15.2%)

1

No

5 (83.3%)

56 (84.8%)